Results 11 to 20 of about 85,174 (277)

How to manage KPC infections [PDF]

open access: yesTherapeutic Advances in Infectious Disease, 2020
Carbapenemase-producing Enterobacteriaceae represent an increasing global threat worldwide and Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae (KPC-KP) has become one of the most important contemporary pathogens, especially in endemic ...
M. Bassetti, M. Peghin
semanticscholar   +6 more sources

Phenotypic and enzymatic comparative analysis of the KPC variants, KPC-2 and its recently discovered variant KPC-15. [PDF]

open access: yesPLoS ONE, 2014
Sixteen different variants (KPC-2 to KPC-17) in the KPC family have been reported, and most current studies are focusing on KPC-2 and KPC-3. The KPC-15 variant, which isolated from Klebsiella pneumoniae in a Chinese hospital, was a recently discovered ...
Dongguo Wang   +4 more
doaj   +5 more sources

Unravelling ceftazidime/avibactam resistance of KPC-28, a KPC-2 variant lacking carbapenemase activity. [PDF]

open access: yesJournal of Antimicrobial Chemotherapy, 2019
BACKGROUND KPC-like carbapenemases have spread worldwide with more than 30 variants identified that differ by single or double amino-acid substitutions. OBJECTIVES To describe the steady-state kinetic parameters of KPC-28, which differs from KPC-2 by a
S. Oueslati   +9 more
semanticscholar   +4 more sources

Management of KPC-producing Klebsiella pneumoniae infections. [PDF]

open access: yesClinical Microbiology and Infection, 2017
Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae (KPC-KP) has become one of the most important contemporary pathogens, especially in endemic ...
M. Bassetti   +14 more
semanticscholar   +10 more sources

A Novel KPC Variant KPC-55 in Klebsiella pneumoniae ST307 of Reinforced Meropenem-Hydrolyzing Activity [PDF]

open access: yesFrontiers in Microbiology, 2020
A novel Klebsiella pneumoniae carbapenemase (KPC) variant, KPC-55, produced by a K. pneumoniae ST307 strain was characterized. K. pneumoniae strain BS407 was recovered from an active surveillance rectal swab of a patient newly admitted to a general ...
정석훈, 최종락
core   +6 more sources

Identification of two KPC variants, KPC-204 and KPC-227, in ST11-K64 Klebsiella pneumoniae during prolonged hospitalization of a single patient [PDF]

open access: yesFrontiers in Microbiology
IntroductionCarbapenem-resistant Klebsiella pneumoniae (CRKP) represents a critical global public health challenge due to its significant association with morbidity and mortality.
Chaoe Zhou   +6 more
core   +4 more sources

Reduced mortality from KPC-K.pneumoniae bloodstream infection in high-risk patients with hematological malignancies colonized by KPC-K.pneumoniae [PDF]

open access: yesBMC Infectious Diseases, 2020
KPC-K.pneumoniae bloodstream infection (KPC-KpBSI) mortality rate in patients with hematological malignancies is reported about 60%. The initial treatment active against KPC-K.pneumoniae is crucial for survival and KPC-K.pneumoniae rectal colonization ...
A. Micozzi   +12 more
semanticscholar   +2 more sources

Emergence of four cases of KPC-2 and KPC-3-carrying Klebsiella pneumoniae introduced to Switzerland, 2009-10 [PDF]

open access: yesEurosurveillance, 2011
We report four epidemiologically unrelated cases of KPC-carrying Klebsiella pneumoniae identified in Switzerland between May 2009 and November 2010. Three cases were transferred from Italy (two KPC-3, one KPC-2) and one from Greece (KPC-2). Resistance to
Droz, S   +21 more
core   +5 more sources

Relebactam Is a Potent Inhibitor of the KPC-2 β-Lactamase and Restores Imipenem Susceptibility in KPC-Producing Enterobacteriaceae [PDF]

open access: yesAntimicrobial Agents and Chemotherapy, 2018
The imipenem-relebactam combination is in development as a potential treatment regimen for infections caused by Enterobacteriaceae possessing complex β-lactamase backgrounds.
Krisztina M. Papp-Wallace   +9 more
core   +3 more sources

KPC-53, a KPC-3 variant of clinical origin associated with reduced susceptibility to ceftazidime-avibactam

open access: yesAntimicrobial Agents and Chemotherapy, 2021
This study reports on the characterization of a Klebsiella pneumoniae clinical isolate showing high-level resistance to ceftazidime-avibactam associated with the production of KPC-53, a KPC-3 variant exhibiting a Leu167Glu168 duplication in the Ω-loop ...
Di Pilato V.   +7 more
core   +4 more sources

Home - About - Disclaimer - Privacy